Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
BIO-B
— Bio-Rad Laboratories, Inc.
NYSE
FULL STOCK PAGE →
Q2 2026 Earnings Call Summary
AUG 4, 2026
REVENUE
$651.0M
+9.9%
NET MARGIN
57.1%
+146.1 PTS
EPS
$13.89
+171.0%
FREE CASH FLOW
$66.7M
-14.6%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 4
OLDER CALL →